Secondary Cytogenetic Abnormalities in Core-Binding Factor AML Harboring inv(16) vs t(8;21)
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Secondary Cytogenetic Abnormalities in Core-Binding Factor AML Harboring inv(16) vs t(8;21)
Blood Adv 2021 May 25;5(10)2481-2489, SY Han, K Mrózek, J Voutsinas, Q Wu, EA Morgan, H Vestergaard, R Ohgami, PM Kluin, TK Kristensen, S Pullarkat, MB Møller, AI Schiefer, LB Baughn, Y Kim, D Czuchlewski, JR Hilberink, HP Horny, TI George, M Dolan, NK Ku, C Arana Yi, V Pullarkat, J Kohlschmidt, A Salhotra, L Soma, CD Bloomfield, D Chen, WR Sperr, G Marcucci, C Cho, C Akin, J Gotlib, S Broesby-Olsen, M Larson, MA Linden, HJ Deeg, G Hoermann, MA Perales, JL Hornick, MR Litzow, R Nakamura, D Weisdorf, G Borthakur, G Huls, P Valent, C Ustun, CCS YeungFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.